Pricing Log in Create free account
Saturday 17 October 2026 Export HRMY’s income statement to Excel — free account

Harmony Biosciences Holdings, Inc.

HRMY Healthcare Biotechnology

Harmony Biosciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $868.5 million, up 21.5% from fiscal 2024. In the quarter to June 2026, revenue grew 30.3%, EPS grew 88.4%, free cash flow grew 16.5% and total debt fell 10.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for five.

38.20 0.07 −0.18%
Market cap
$2.2B
P/E
12.2×
Fwd P/E
9.4×
Dividend yield
—
F-score
5/9
Altman Z
5.23
Beneish M
−2.99
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Harmony Biosciences Holdings, Inc. (HRMY) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Harmony Biosciences Holdings, Inc. (HRMY) trades at a P/E ratio of 12.2×. Over the past ten years it has ranged from 0.0× (June 2021) to 209× (December 2021); the current reading is higher than 40% of that period. That is above the Biotechnology industry median of 8.5× and below the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 13.6× 1.23%
FY2024 13.4× (5.70%)
FY2023 14.3× (17.64%)
FY2022 17.3× (75.65%)
FY2021 71.1× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period P/E ratio Change
Jun 2026 11.6× 4.66%
Mar 2026 11.1× (18.32%)
Dec 2025 13.6× 59.48%
Sep 2025 8.5× (14.67%)
22 more quarters

Against its own ten years

Low 0.0× High 209×
Ten-year median 13.0×
Current reading's percentile 30

P/E ratio against peers

Company P/E ratio
NVAX Novavax, Inc. compare n/m
IRON Disc Medicine, Inc. compare n/m
VRDN Viridian Therapeutics, Inc. compare n/m
SLS SELLAS Life Sciences Group, Inc. compare n/m
FTRE Fortrea Holdings Inc. compare n/m
RXRX Recursion Pharmaceuticals, Inc. compare n/m
CLDX Celldex Therapeutics, Inc. compare n/m
AUPH Aurinia Pharmaceuticals Inc compare 6.9×
HRMY Harmony Biosciences Holdings, Inc. 12.2×
Biotechnology industry median 8.5×
Healthcare sector median 23.0×
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on HRMY